PT Merck Tbk (IDX:MERK)
Indonesia · Delayed Price · Currency is IDR 3,610.00
0.00 (0.00%)
Oct 30, 2026, 4:03 PM WIB
PT Merck Tbk Financials Overview
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,375,670 | 1,200,667 | 1,036,748 | 961,434 | 1,124,600 | 1,064,395 |
Revenue Growth | 25.39% | 15.81% | 7.83% | -14.51% | 5.66% | 62.29% |
Gross Profit Gross Profit Growth | 585,256 | 571,302 | 402,666 | 400,472 | 427,592 | 398,684 |
Operating Income Operating Income Growth | 327,840 | 321,355 | 193,909 | 199,638 | 237,017 | 191,446 |
Net Income Net Income Growth | 238,517 | 243,896 | 153,463 | 178,240 | 179,838 | 131,661 |
Earnings Per Share EPS Growth | 532.43 | 544.41 | 342.55 | 397.86 | 401.42 | 293.89 |
EPS Growth | 33.58% | 58.93% | -13.90% | -0.89% | 36.59% | 83.11% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Biopharma Biopharma Growth | 732,391 | 710,112 | 722,562 | 709,854 | 734,254 | 594,312 |
Consumer Health Consumer Health Growth | 618,355 | 490,555 | 314,186 | 222,150 | 291,029 | 375,878 |
Total Total Growth | 1,350,746 | 1,200,667 | 1,036,748 | 961,434 | 1,124,600 | 1,064,395 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 465,123 | 363,850 | 87,684 | 201,437 | 170,428 | 196,343 |
Total Debt Total Debt Growth | 15,955 | 14,229 | 20,213 | 18,133 | 16,183 | 20,282 |
Net Cash (Debt) Net Cash Growth | 449,168 | 349,622 | 67,471 | 183,304 | 154,245 | 176,061 |
Net Cash Growth | 186.75% | 418.18% | -63.19% | 18.84% | -12.39% | 56.21% |
Net Cash Per Share Net Cash Per Share Growth | 1002.65 | 780.41 | 150.61 | 409.16 | 344.30 | 392.99 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 519,090 | 376,518 | 55,712 | 203,875 | 110,323 | 169,815 |
Capital Expenditures CapEx Growth | -22,389 | -15,620 | -16,351 | -19,184 | -20,038 | -42,972 |
Free Cash Flow Free Cash Flow Growth | 496,700 | 360,898 | 39,360 | 184,691 | 90,285 | 126,843 |
Free Cash Flow Growth | 37.81% | 816.91% | -78.69% | 104.56% | -28.82% | 211.11% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 42.54% | 47.58% | 38.84% | 41.65% | 38.02% | 37.46% |
Operating Margin | 23.83% | 26.77% | 18.70% | 20.77% | 21.08% | 17.99% |
Pretax Margin | 25.26% | 27.26% | 18.82% | 21.13% | 21.14% | 17.90% |
Profit Margin | 17.34% | 20.31% | 14.80% | 18.54% | 15.99% | 12.37% |
FCF Margin | 36.11% | 30.06% | 3.80% | 19.21% | 8.03% | 11.92% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 275.000 | 275.000 | 170.000 | 320.000 | 320.000 | 240.000 |
Dividend Per Share Growth | 61.76% | 61.77% | -46.88% | 0% | 33.33% | 96.72% |
Dividend Yield | 7.62% | 8.21% | 4.72% | 7.66% | 6.74% | 6.50% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 6.78 | 6.15 | 10.51 | 10.51 | 11.83 | 12.56 |
P/FCF Ratio | 3.26 | 4.16 | 40.98 | 10.14 | 23.57 | 13.03 |
PS Ratio | 1.18 | 1.25 | 1.56 | 1.95 | 1.89 | 1.55 |